Integrated harm reduction services for Black and Latinx individuals who use drugs
Official title: Culturally Response Integrated Harm Reduction Services for Black and Latinx People Who use Drugs
Funded at New York University School of Medicine · NIH-10590442 · Data updated 2026-11-12
This study is working to create better support and treatment options for Black and Latinx individuals who use drugs, making it easier for them to get the help they need in a way that respects their culture and unique challenges.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 30, 2022 |
| Project end | September 29, 2025 |
| Funding year | 2022 |
| Award (this year) | $2,125,558 |
| NIH project number | 1R01DA057651-01 |
| Project ID | NIH-10590442 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Black and Latinx individuals who use drugs and are seeking support for substance use issues.
✕Less likely to help
Patients who do not identify as Black or Latinx or who do not use drugs may not receive benefit from this research.
What this research studies
This research focuses on developing culturally responsive harm reduction services specifically for Black and Latinx individuals who use drugs. It aims to address the unique challenges these communities face in accessing treatment and support for substance use disorders. The approach includes mobile and flexible interventions that assess social determinants of health and connect individuals to necessary services. By employing harm reduction care coordinators, the project seeks to improve retention in treatment and reduce the negative consequences of substance misuse.
Why it matters
Potential benefit: If successful, this research could significantly improve access to and effectiveness of treatment for substance use disorders among Black and Latinx populations.
How similar studies have gone: Previous research has shown success in harm reduction approaches tailored to specific communities, indicating potential for positive outcomes in this novel intervention.
Where this research is happening
-
New York University School of Medicine
New York, United States Active
Researchers
- Principal investigator: Jordan, Ayana — New York University School of Medicine
- Study coordinator: Jordan, Ayana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.